Some biotech firms have been outperforming the market over the past few weeks on their treatment initiatives.
"At least a dozen companies have informally or formally announced vaccine or drug development initiatives to address" the virus, Needham's analyst Alan Carr said in a note. "It appears at least a few programs will have moved into clinical testing within a few months."
These programs include drugs already approved for other viral infections, unapproved drugs initially developed for other viruses, new monoclonal antibodies, new vaccines, the analyst pointed out.skyrocketed 37% in January as it said it's in the process of developing a vaccine against the new deadly virus.
But analysts cautioned any commercial treatment from Inovio could be years away. Buyers in these stocks should beware as that could be the issue with any of these names amid the rampant speculation., who recently indicated that it is working on a potential vaccine for the coronavirus. "Moderna has a potential benefit over traditional vaccine makers in that once it has the sequences that code for the most immunogenic part of the virus' surface proteins, or antigens, management can rapidly make a clinical development candidate," the bank's analyst Matthew Harrison said in a note., who said it's screening technology to potentially produce therapeutic antibodies against the virus.
"During the Ebola outbreak, Regeneron was able to move from development to validation of its therapeutic candidate in 6 months," Harrison said.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Weekend reads: It’s only a matter of time before Tesla’s stock gets this huge supportWeekend reads: Tesla's future, the coronavirus effect on stocks, how to improve your FICO score and more.
Baca lebih lajut »
How far away is a coronavirus vaccine?Over 200 people have died since 2019-nCoV emerged in China late last year.
Baca lebih lajut »
Inside the Company That's Hot Wiring Vaccine Research in the Race to Combat the CoronavirusResearchers at the National Institutes of Health are working with biotech company Moderna Therapeutics to develop and test a vaccine against the latest viral outbreak
Baca lebih lajut »
How the feds missed their chance at a coronavirus vaccineScientists say interest — and funding — waned after SARS died out.
Baca lebih lajut »
Opinion | Pharma to the RescueFrom WSJopinion: Advances in drug research mean a vaccine for the coronavirus could be in human trials by April, writes The Editorial Board
Baca lebih lajut »